EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. It offers comprehensive contract research organization and contract manufacturing organization services. Its products include Euvichol, oral cholera vaccine, enteric infection vaccine, and anti-cancer vaccine. The company was founded on March 10, 2010 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company